BRCA1 and ovarian cancer: The BOADICEA model similarly predicts the probability of carrying a BRCA1 or BRCA2 mutation, but works by determining the age and status of breast and ovarian cancer in all of the patient’s available relatives, while still being guided by the prevalence and penetrance of BRCA1 and BRCA2 mutation in carriers.